| __timestamp | Iovance Biotherapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 2999000 |
| Thursday, January 1, 2015 | 12390000 | 10393000 |
| Friday, January 1, 2016 | 25602000 | 15994000 |
| Sunday, January 1, 2017 | 21262000 | 26975000 |
| Monday, January 1, 2018 | 28430000 | 39509000 |
| Tuesday, January 1, 2019 | 40849000 | 48869000 |
| Wednesday, January 1, 2020 | 60210000 | 42510000 |
| Friday, January 1, 2021 | 83664000 | 46105000 |
| Saturday, January 1, 2022 | 104097000 | 50513000 |
| Sunday, January 1, 2023 | 106916000 | 51292000 |
Unleashing insights
In the dynamic world of biotechnology, managing costs is crucial for sustaining innovation. Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd. have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Iovance's SG&A expenses surged by over 1,000%, reflecting its aggressive expansion and investment in groundbreaking therapies. In contrast, Wave Life Sciences exhibited a more moderate increase of approximately 1,600%, indicating a steady yet strategic approach to cost management.
By 2023, Iovance's SG&A expenses reached nearly double those of Wave Life Sciences, highlighting its commitment to scaling operations. This financial narrative underscores the diverse strategies employed by biotech firms to balance growth and fiscal responsibility. As these companies continue to innovate, their cost management strategies will play a pivotal role in shaping their future success.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for argenx SE and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Grifols, S.A. or Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights